Ascending Single Doses of Erenumab (AMG 334) in Healthy Adults and Migraine Patients
Clinical trial NCT01688739 · COMPLETED
Trial details
- NCT number
- NCT01688739
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-13
- Primary completion
- 2013-03-27
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.